What one share of Palomino Laboratories holds
The business purpose of the Company is to seek the acquisition of or merger with, an existing
Palomino Laboratories’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Profit | −$0.33 |
|---|---|
| Cash and investments | $0.84 |
| Debt | $0.00 |
| Book value | $0.89 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2023 | — | −$0.05 | — | — | — | −$0.00 |
| 2024 | — | −$0.01 | — | — | — | — |
| 2025 | — | −$0.47 | — | — | — | $0.43 |
Common questions about Palomino Laboratories
How much does one share of Palomino Laboratories earn?
Over the last 12 months, Palomino Laboratories lost $0.33 for each share.
Does Palomino Laboratories pay a dividend?
Palomino Laboratories didn’t pay a dividend over the last 12 months, according to its SEC filings.
What is Palomino Laboratories’s book value per share?
Palomino Laboratories’s book value is $0.89 per share: what would be left for each share if it sold everything at the values on its books and paid every debt, as of June 30, 2026.
How much cash and debt does each share of Palomino Laboratories have?
Each share of Palomino Laboratories has $0.84 of cash and investments and $0.00 of debt, as of June 30, 2026.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.